Back to top
more

ARK Genomic Revolution ETF: (ARKG)

(Real Time Quote from BATS) As of Nov 19, 2026 01:00 PM ET

$41.00 USD

41
2,360,397

-0.26 (-0.63%)

Volume: 2,360,397

Zacks ETF Rank

This is our ETF rating system that serves as a timeliness indicator for ETFs over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

See all the Top Ranked ETFs here - The complete list of all the top ranked ETFs

NA

Zacks News

Kevin Cook headshot

Why Gold is Headed to Zero -- And What You Should Buy Instead

In 2026, NASA mission Psyche will explore an asteroid that could hold over $5,000 quadrillion in gold

Sweta Jaiswal, FRM headshot

Genomics ETFs Surge on CRISPR's Gene Editing Progress

The release of encouraging data on the CRISPR/Cas9 gene-editing therapy CTX001 for two severe blood disorders puts emphasis on some genomic ETFs.

Sanghamitra Saha headshot

Healthcare Drives Wall Street: 5 Soaring ETFs & Stocks

Decent fundamentals and valuations as well as encouraging developments put these medical ETFs and stocks in focus.

Sweta Killa headshot

S&P 500 at Record High: 6 ETF Winners of Last Week

The S&P 500 hit record highs last week, with the index rising for the fourth consecutive week, marking its longest winning streak since March.

Panel Of Zacks Experts headshot

Navigating The Healthcare Industry: Science Fiction Turns to Reality

Kevin Cook joins us to help walk us through the maze that is the healthcare industry. We touch on everything from the hottest trends all the way down to how to pick a winning stock!

Sanghamitra Saha headshot

Tap Revenue Growth With These ETFs & Dump Earnings Recession

These sector ETFs could be played to highlight revenue growth in the third quarter.

Sweta Jaiswal, FRM headshot

ETFs Poised to Benefit from Gene Editing Revolution

Rising investments and growing technological advancement are favoring the genomic editing space. We take a look at a few ETFs that can cash in on this trend.

Sweta Jaiswal, FRM headshot

ETFs to Gain From the Booming Genomics Market

Rising investments, surging demand for personalized medicines and shrinking sequencing costs are a slew of factors favouring the genomics space. We look at a few ETFs that can cash in on this trend.

Sweta Jaiswal, FRM headshot

Top-Performing Biotech ETFs YTD

Increasing M&A deals, growing AI dominance and favorable regulatory tidings continue to boost the biotech stocks. Accordingly, we take a look at biotech ETFs gaining more than 10% year to date.

Sweta Killa headshot

5 U.S. ETFs Seeing Fireworks Ahead of July Fourth

These ETFs focus exclusively on U.S. equities and deserve the attention of investors seeking a domestic tilt to their portfolio ahead of the Jul 4 holiday.